STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Activity
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

29 hedge funds and large institutions have $200K invested in Statera Biopharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.

Holders
29
Holders Change
-6
Holders Change %
-17.14%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
9
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$34K
2
Millennium Management
2
Millennium Management
New York
$5K
3
E
3
Ergoteles
New York
$2.3K
4
HF
4
HRT Financial
New York
$1K
5
Osaic Holdings
5
Osaic Holdings
Arizona
$2K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$59K
2
RJFSA
2
Raymond James Financial Services Advisors
Florida
$0
3
VF
3
Virtu Financial
New York
$0
4
UBS Group
4
UBS Group
Switzerland
$161
5
Two Sigma Investments
5
Two Sigma Investments
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$5 +$5 +59 +5,900%
VF
27
Virtu Financial
New York
– -$13K -102,385 Closed
RJFSA
28
Raymond James Financial Services Advisors
Florida
– -$13K -102,250 Closed
Two Sigma Investments
29
Two Sigma Investments
New York
– -$5K -37,272 Closed
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
– -$2K -16,228 Closed
SCP
31
Sandhill Capital Partners
New York
– -$2K -13,570 Closed
FP
32
Financial Perspectives
Minnesota
– -$1.16K -8,941 Closed
1
2